LEADER 01003nam--2200373---450- 001 990006122810203316 005 20160209101838.0 010 $a0-19-815245-0 035 $a000612281 035 $aUSA01000612281 035 $a(ALEPH)000612281USA01 035 $a000612281 100 $a20160209d1998----km-y0itay50------ba 101 $aeng 102 $aGB 105 $a||||||||001yy 200 1 $a<> madness of epic$ereading insanity from Homer to Statius$fDebra Hershkowitz 210 $aOxford$cClarendon Press$dc. 1998 215 $aXIII,346 p.$d23 cm 225 2 $aOxford classical monographs 410 0$12001 454 1$12001 461 1$1001-------$12001 606 0 $aPazzia$2BNCF 676 $a362.2 700 1$aHERSHKOWITZ,$bDebra$0526168 801 0$aIT$bsalbc$gISBD 912 $a990006122810203316 951 $aCI 92$b8776 DSA 959 $aBK 969 $aDSA 979 $aDSA$b90$c20160209$lUSA01$h1018 996 $aMadness of epic$9869446 997 $aUNISA LEADER 01560nam 2200361 n 450 001 996392545103316 005 20200824121749.0 035 $a(CKB)4940000000107912 035 $a(EEBO)2240950523 035 $a(UnM)99862469e 035 $a(UnM)99862469 035 $a(EXLCZ)994940000000107912 100 $a19921203d1648 uy | 101 0 $aeng 135 $aurbn||||a|bb| 200 10$aLondon, King Charles his Augusta, or, city royal$b[electronic resource] $eOf the founders, the names, and oldest honours of that city. An historicall and antiquarian work. Written at first in heroicall Latin verse, according to Greek, Roman, British, English, and other antiquities and authorities, and now translated into English couplets, with annotations. Imprimatur, Na. Brent 210 $aLondon $cPrinted for William Leybourn$d1648 215 $a[8], 12 p 300 $aSir William D'Avenant's name appears in the Address to the Reader. 300 $aImperfect: staining. 300 $aAnnotation on Thomason copy: "March 7th 1648"; the '8' in imprint date is crossed out and replaced with '7'. 300 $aReproduction of the original in the British Library. 330 $aeebo-0018 607 $aLondon (England)$xHistory$vPoetry$vEarly works to 1800 700 $aD'Avenant$b William$cSir,$f1606-1668.$0197821 801 0$bCu-RivES 801 1$bCu-RivES 801 2$bCStRLIN 801 2$bWaOLN 906 $aBOOK 912 $a996392545103316 996 $aLondon, King Charles his Augusta, or, city royal$92372653 997 $aUNISA LEADER 02627nam 2200601 a 450 001 9910789402403321 005 20200520144314.0 010 $a1-84973-275-2 035 $a(CKB)2670000000096417 035 $a(EBL)1185170 035 $a(OCoLC)730289308 035 $a(SSID)ssj0000578382 035 $a(PQKBManifestationID)12198039 035 $a(PQKBTitleCode)TC0000578382 035 $a(PQKBWorkID)10577999 035 $a(PQKB)11469595 035 $a(MiAaPQ)EBC1185170 035 $a(Au-PeEL)EBL1185170 035 $a(CaPaEBR)ebr10627633 035 $a(CaONFJC)MIL872272 035 $a(PPN)198470258 035 $a(EXLCZ)992670000000096417 100 $a20121208d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAnimal models for neurodegenerative disease$b[electronic resource] /$fedited by Jesu?s Avila, Jose J. Lucas and Fe?lix Herna?ndez 210 $aCambridge [England] $cRSC Pub.$d2011 215 $a1 online resource (307 p.) 225 0$aRSC drug discovery series,$x2041-3203 ;$v6 300 $aDescription based upon print version of record. 311 $a1-84973-184-5 320 $aIncludes bibliographical references and index. 327 $ai-iv; v-viii; ix-xvi; 1-14; 15-38; 39-51; 52-68; 69-85; 86-112; 113-161; 162-176; 177-213; 214-229; 230-250; 251-273; 274-283; 284-290 330 $aIn recent years, medical developments have resulted in an increase in human life expectancy. Some developed countries now have a larger population of individuals aged over 64 than those under 14. One consequence of the ageing population is a higher incidence of certain neurodegenerative disorders. In order to prevent these, we need to learn more about them. This book provides up-to-date information on the use of transgenic mouse models in the study of neurodegenerative disorders such as Alzheimer's and Huntington's disease. By reproducing some of the pathological aspects of the diseases, these 410 0$aRSC Drug Discovery 606 $aNervous system$xDegeneration 606 $aNervous system$xDegeneration$xAnimal models 615 0$aNervous system$xDegeneration. 615 0$aNervous system$xDegeneration$xAnimal models. 676 $a616.83 701 $aAvila$b Jesu?s$01143092 701 $aLucas$b Jose? J$01487313 701 $aHerna?ndez$b Fe?lix$01487314 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910789402403321 996 $aAnimal models for neurodegenerative disease$93707108 997 $aUNINA